We report the first case in Ireland of an IMI-1 carbapenemase-producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should be aware of the unusual antibiograms of IMI-producing isolates.
CITATION STYLE
Boo, T. W., O’Connell, N., Power, L., O’Connor, M., King, J., McGrath, E., … Woodford, N. (2013). First report of IMI-1-producing colistin-resistant enterobacter clinical isolate in Ireland, March 2013. Eurosurveillance, 18(31). https://doi.org/10.2807/1560-7917.ES2013.18.31.20548
Mendeley helps you to discover research relevant for your work.